Molecular Carcinogenesis · 1992 · 42 citations · 48 references
MedicineGeneticsOncologyCarcinogenesisCell ProliferationOncogenesCancer ProgressionNeoplastic TransformationOncogene ActivationOncogene MutationsRas Family OncogenesThyroid CancerActivating MutationsBenign Thyroid NeoplasmsBenign Thyroid TumorsMutationOncogenic TransformationRas-driven TumorigenesisThyroid AdenomasThyroid Follicular Cell Biology
Activating mutations of the ras oncogene family occur at high frequency in all stages of thyroid tumorigenesis, both human and experimental. To test the causal nature of this association, and to investigate the biological role of ras mutation, we introduced a mutant c-Ha-ras gene into normal rat thyroid follicular cells using an ecotropic retroviral vector. The major immediate effect was to greatly extend the proliferative lifespan of these cells in culture from less than 3 to more than 15 doublings, without any observable loss of growth-factor dependence or differentiated functions. This in vitro phenotype strongly supports an initiating role for ras mutation in the genesis of benign thyroid tumors (adenomas) in vivo. Spontaneous transformation was observed at low frequency on continuous culture of mutant ras-expressing cells, giving rise to fully immortalized, growth factor-independent, highly tumorigenic lines. Transformation was associated with (i) loss of responsiveness to the growth inhibitor TGF-beta 1, and (ii) greatly increased nuclear levels of p53 protein, which unexpectedly was not due to point mutation in the conserved regions of the p53-coding sequence. We postulate that these two phenomena are causally related to each other and to the transformed phenotype.
48
Mutations in the p53 gene occur in diverse human tumour types
Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature · 1989 · 2.8K citations · Full text
Increased expression of mutant forms of p53 oncogene in primary lung cancer
Richard Iggo, Jiří Bártek, David P. Lane et al. · The Lancet · 1990 · 1K citations